Olafur Palsson
1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis
(
- Contribution to journal › Article
-
Mark
Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis : results from nine European registries
(
- Contribution to journal › Article
-
Mark
Challenge of missing data in observational studies : investigating cross-sectional imputation methods for assessing disease activity in axial spondyloarthritis
(
- Contribution to journal › Article
- 2024
-
Mark
Prescription of non-steroidal anti-inflammatory drugs for patients with inflammatory arthritis decreases with the initiation of tumour necrosis factor inhibitor therapy : results from the ICEBIO registry
(
- Contribution to journal › Article
-
Mark
Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis : results from nine European rheumatology registries
(
- Contribution to journal › Article
- 2022
-
Mark
Outpatient Use of Antimicrobials in Patients With Rheumatoid Arthritis Before and After Treatment With Tumor Necrosis Factor Inhibitors : A Nationwide Retrospective Cohort Study
(
- Contribution to journal › Article